JULY 1st, 2020
Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure. Read the Press Release
JULY 1st, 2020
Biophytis announces the issuance of a €3 million tranche of ORNANE. Read the Press Release